Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 304

1.

Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.

Sarker AR, Islam Z, Khan IA, Saha A, Chowdhury F, Khan AI, Cravioto A, Clemens JD, Qadri F, Khan JA.

Vaccine. 2015 Jul 29. pii: S0264-410X(15)00989-5. doi: 10.1016/j.vaccine.2015.07.042. [Epub ahead of print]

PMID:
26232545
2.

Role of phytoplankton in maintaining endemicity and seasonality of cholera in Bangladesh.

Islam MS, Islam MS, Mahmud ZH, Cairncross S, Clemens JD, Collins AE.

Trans R Soc Trop Med Hyg. 2015 Jul 14. pii: trv057. [Epub ahead of print]

PMID:
26179653
3.

Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.

Qadri F, Ali M, Chowdhury F, Khan AI, Saha A, Khan IA, Begum YA, Bhuiyan TR, Chowdhury MI, Uddin MJ, Khan JA, Chowdhury AI, Rahman A, Siddique SA, Asaduzzaman M, Akter A, Khan A, Ae You Y, Siddik AU, Saha NC, Kabir A, Riaz BK, Biswas SK, Begum F, Unicomb L, Luby SP, Cravioto A, Clemens JD.

Lancet. 2015 Jul 8. pii: S0140-6736(15)61140-0. doi: 10.1016/S0140-6736(15)61140-0. [Epub ahead of print]

PMID:
26164097
4.

A model immunization programme to control Japanese encephalitis in Viet Nam.

Yen NT, Liu W, Hanh HD, Chang NY, Duong TN, Gibbons RV, Marks F, Thu NA, Hong NM, Park JK, Tuan PA, Nisalak A, Clemens JD, Xu ZY.

J Health Popul Nutr. 2015 Mar;33(1):207-13.

5.

Typhoid vaccine introduction: An evidence-based pilot implementation project in Nepal and Pakistan.

Khan MI, Pach A 3rd, Khan GM, Bajracharya D, Sahastrabuddhe S, Bhutta W, Tahir R, Soofi S, Thapa CB, Joshi N, Puri MK, Shrestha P, Upreti SR, Clemens JD, Bhutta Z, Ochiai RL.

Vaccine. 2015 Jun 19;33 Suppl 3:C62-C67. doi: 10.1016/j.vaccine.2015.03.087. Epub 2015 Apr 30. Review.

PMID:
25937612
6.

Vaccine introduction in the Democratic People's Republic of Korea.

Marks F, Nyambat B, Xu ZY, von Kalckreuth V, Kilgore PE, Seo HJ, Du Y, Park SE, Im J, Konings F, Meyer CG, Wierzba TF, Clemens JD.

Vaccine. 2015 May 11;33(20):2297-300. doi: 10.1016/j.vaccine.2015.03.005. Epub 2015 Mar 10.

PMID:
25769209
7.

Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.

Kanungo S, Desai SN, Nandy RK, Bhattacharya MK, Kim DR, Sinha A, Mahapatra T, Yang JS, Lopez AL, Manna B, Bannerjee B, Ali M, Dhingra MS, Chandra AM, Clemens JD, Sur D, Wierzba TF.

PLoS Negl Trop Dis. 2015 Mar 12;9(3):e0003574. doi: 10.1371/journal.pntd.0003574. eCollection 2015 Mar.

8.

Phenotypic and genotypic characteristics of Vibrio cholerae O1 isolated from the Sierra Leone cholera outbreak in 2012.

Mahmud ZH, Islam S, Zaman RU, Akter M, Talukder KA, Bardhan PK, Khan AI, Rhodes FC, Kamara A, Wurie IM, Alemu W, Jambai A, Faruque SM, Clemens JD, Islam MS.

Trans R Soc Trop Med Hyg. 2014 Nov;108(11):715-20. doi: 10.1093/trstmh/tru137. Epub 2014 Sep 18.

PMID:
25233936
9.

Molecular insights into the evolutionary pathway of Vibrio cholerae O1 atypical El Tor variants.

Kim EJ, Lee D, Moon SH, Lee CH, Kim SJ, Lee JH, Kim JO, Song M, Das B, Clemens JD, Pape JW, Nair GB, Kim DW.

PLoS Pathog. 2014 Sep 18;10(9):e1004384. doi: 10.1371/journal.ppat.1004384. eCollection 2014 Sep.

10.

Coverage and acceptability of cholera vaccine among high-risk population of urban Dhaka, Bangladesh.

Uddin MJ, Wahed T, Saha NC, Kaukab SS, Khan IA, Khan AI, Saha A, Chowdhury F, Clemens JD, Qadri F.

Vaccine. 2014 Sep 29;32(43):5690-5. doi: 10.1016/j.vaccine.2014.08.021. Epub 2014 Aug 20.

PMID:
25149429
11.

Considerations around the introduction of a cholera vaccine in Bangladesh.

Nelson CB, Mogasale V, Bari TI, Clemens JD.

Vaccine. 2014 Dec 12;32(52):7033-6. doi: 10.1016/j.vaccine.2014.05.028. Epub 2014 May 20.

PMID:
24856784
12.

Assessing effects of cholera vaccination in the presence of interference.

Perez-Heydrich C, Hudgens MG, Halloran ME, Clemens JD, Ali M, Emch ME.

Biometrics. 2014 Sep;70(3):731-41. doi: 10.1111/biom.12184. Epub 2014 May 20.

13.

Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.

Kanungo S, Lopez AL, Ali M, Manna B, Kim DR, Mahapatra T, Holmgren J, Dhingra MS, Weirzba TF, Nair GB, Bhattacharya SK, Clemens JD, Sur D.

PLoS One. 2014 May 6;9(5):e96499. doi: 10.1371/journal.pone.0096499. eCollection 2014.

14.

Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India.

Ochiai RL, Khan MI, Soofi SB, Sur D, Kanungo S, You YA, Habib MA, Sahito SM, Manna B, Dutta S, Acosta CJ, Ali M, Bhattacharya SK, Bhutta ZA, Clemens JD.

Clin Vaccine Immunol. 2014 May;21(5):661-6. doi: 10.1128/CVI.00791-13. Epub 2014 Mar 5.

15.

Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.

Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, Rath SB, Ali M, Mogasale V, Khuntia HK, Bhattachan A, You YA, Puri MK, Lopez AL, Maskery B, Nair GB, Clemens JD, Wierzba TF.

PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2629. doi: 10.1371/journal.pntd.0002629. eCollection 2014 Feb.

16.

Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study.

Punjabi NH, Agtini MD, Ochiai RL, Simanjuntak CH, Lesmana M, Subekti D, Oyofo BA, von Seidlein L, Deen J, Shin S, Acosta C, Wangsasaputra F, Pulungsih SP, Saroso S, Suyeti S, R S, Sudarmono P, Syarurachman A, Suwandono A, Arjoso S, Beecham HJ 3rd, Corwin AL, Clemens JD.

J Infect Dev Ctries. 2013 Nov 15;7(11):781-7. doi: 10.3855/jidc.2629.

17.

Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.

Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, Riaz BK, Islam S, Ali M, Luby SP, Clemens JD, Cravioto A, Qadri F.

Vaccine. 2013 Dec 9;31(51):6058-64. doi: 10.1016/j.vaccine.2013.10.021. Epub 2013 Oct 22.

18.

Strategy, demand, management, and costs of an international cholera vaccine stockpile.

Maskery B, DeRoeck D, Levin A, Kim YE, Wierzba TF, Clemens JD.

J Infect Dis. 2013 Nov 1;208 Suppl 1:S15-22. doi: 10.1093/infdis/jit233. Review.

19.

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, Sah B, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Dhingra MS, Donner A, Nair GB, Lopez AL, Wierzba TF, Clemens JD.

Lancet Infect Dis. 2013 Dec;13(12):1050-6. doi: 10.1016/S1473-3099(13)70273-1. Epub 2013 Oct 18. Erratum in: Lancet Infect Dis. 2013 Dec;13(12):1011.

PMID:
24140390
20.

Formative research and development of an evidence-based communication strategy: the introduction of Vi typhoid fever vaccine among school-aged children in Karachi, Pakistan.

Pach A, Tabbusam G, Khan MI, Suhag Z, Hussain I, Hussain E, Mumtaz U, Haq IU, Tahir R, Mirani A, Yousafzai A, Sahastrabuddhe S, Ochiai RL, Soofi S, Clemens JD, Favorov MO, Bhutta ZA.

J Health Commun. 2013;18(3):306-24. doi: 10.1080/10810730.2012.727958. Epub 2013 Jan 18.

PMID:
23330632
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk